Impact of Pyridoxine Supplement on Oxidative Stress in Type 2 Diabetic Patients

Authors

  • Moatamad Hanoon Dawood Department of (Clinical Pharmacy) / College of Pharmacy / Mustansiriyah University
  • Manal Khalid Abdulridha Department of (Clinical Pharmacy) / College of Pharmacy / Mustansiriyah University
  • Hayder Saadoon Qasim Mesan Medical College / Mesan University

DOI:

https://doi.org/10.32947/ajps.v24i1.1030

Keywords:

Pyridoxine supplement, Oxidative stress, Serum malondialdehyde level (MDA)

Abstract

Background: The physiologically active form of vitamin B6 is pyridoxal 5-phosphate (PLP), which functions as a coenzyme in 150 enzymatic processes such amino acid, carbohydrate, and lipid metabolism and is essential for the production and/or breakdown of neurotransmitters.

. It also acts as an antioxidant by quenching Reactive Oxygen Species (ROS) and counteracting the formation of Advanced Glycation End-Product (AGEs). PLP is recycled by mammals from B6 vitamins found in diet and has been linked to a number of clinically significant disorders. This study aim was to evaluate the impact of pyridoxine supplementation on oxidative stress status in type 2 diabetic patients.

Method: This prospective controlled randomized open-labeled study of newly diagnosed T2DM patients. The study was conducted from November 2022 to February 2023 at the Mesan Center for Diabetes and Endocrinology under the supervision of a specialist endocrinologist. The total number of participants whose data were collected in this study was one hundred and eight participants, eighty-eight patients newly diagnosed with type 2 diabetes were included in the study, and twenty of the participants were healthy subjects. The patients were allocated into three groups: Group 1: Control group, 20 T2DM patients were treated with non-pharmacological therapy (lifestyle modification) for one month, Group 2: 34 T2DM patients treated with metformin 500 mg/day in addition to non-pharmacological therapy (lifestyle modification) for one month, Group 3: 34 T2DM patients treated with metformin 500 mg/day plus vitamin B6 300 mg/day in addition to non-pharmacological therapy (lifestyle modification) for one month, in addition to Healthy subjects: 20 subjects were taken to compare the study parameters between type 2 diabetic patients and healthy persons at baseline. Measurement of Vitamin B6 (pyridoxine) blood level (PLP), body mass index (BMI) and Serum malondialdehyde level (MDA) was done in this study.

Results: The results of the study showed that the use of pyridoxine supplementation plus metformin decreased the level of MDA. There was significant decrease in (MDA) level (P<0.01) pretreatment when compared to after treatment (3.85 μmole/L vs 1.66 μmole/L) respectively.

Conclusion: Restoration of vitamin B6 level can leads to a decreased blood level of MDA in diabetic patients.

References

- Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–36. DOI: https://doi.org/10.1038/nrendo.2011.183

- Ahmed HS, Thair NT. Chemerin as a New Marker in Iraqi Newly Diagnosed Type 2 Diabetes Mellitus. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2015;15(1):6–13. DOI: https://doi.org/10.32947/ajps.v15i1.159

- Bajaj S, Khan A. Antioxidants and diabetes. Indian J Endocrinol Metab. 2012;16(Suppl 2): S267.

- Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard B V, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134–46. DOI: https://doi.org/10.1161/01.CIR.100.10.1134

- Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi pharmaceutical journal. 2016;24(5):547–53.

- Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203.

- Raveendran A V, Chacko EC, Pappachan JM. Non-pharmacological treatment options in the management of diabetes mellitus. Eur Endocrinol. 2018;14(2):31. DOI: https://doi.org/10.17925/EE.2018.14.2.31

- Najim HD, Majeed IA, Rahmah AM. Effects of Metformin &/or Glimepiride on Resistin Level and Related Biochemical Markers in Type 2 Diabetes Mellitus. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2014;14(2):78–88. DOI: https://doi.org/10.32947/ajps.v14i2.149

- Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005;10(4):229.

- Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203. DOI: https://doi.org/10.2337/dc08-9025

- Lily M, Godwin M. Treating prediabetes with metformin: systematic review and meta-analysis. Canadian Family Physician. 2009;55(4):363–9.

- Group DPPR. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England journal of medicine. 2002;346(6):393–403. DOI: https://doi.org/10.1056/NEJMoa012512

- Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006; 49:289–97. DOI: https://doi.org/10.1007/s00125-005-0097-z

- Di Salvo ML, Contestabile R, Safo MK. Vitamin B6 salvage enzymes: mechanism, structure and regulation. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. 2011;1814(11):1597–608. DOI: https://doi.org/10.1016/j.bbapap.2010.12.006

- Ehrenshaft M, Bilski P, Li MY, Chignell CF, Daub ME. A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis. Proceedings of the National Academy of Sciences. 1999;96(16):9374–8. DOI: https://doi.org/10.1073/pnas.96.16.9374

- Booth AA, Khalifah RG, Todd P, Hudson BG. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs): novel inhibition of post-Amadori glycation pathways. Journal of Biological Chemistry. 1997;272(9):5430–7. DOI: https://doi.org/10.1074/jbc.272.9.5430

- McCormick DB, Chen H. Update on interconversions of vitamin B-6 with its coenzyme. J Nutr. 1999;129(2):325–7.

- Hellmann H, Mooney S. Vitamin B6: a molecule for human health? Molecules. 2010;15(1):442–59. DOI: https://doi.org/10.3390/molecules15010442

- Rubí B. Pyridoxal 5’-phosphate (PLP) deficiency might contribute to the onset of type I diabetes. Med Hypotheses. 2012;78(1):179–82. DOI: https://doi.org/10.1016/j.mehy.2011.10.021

- Okada M, Shibuya M, Yamamoto E, Murakami Y. Effect of diabetes on vitamin B6 requirement in experimental animals. Diabetes Obes Metab. 1999;1(4):221–5.

- Jain SK. Vitamin B6 (pyridoxamine) supplementation and complications of diabetes. Metabolism-Clinical and Experimental. 2007;56(2):168–71. DOI: https://doi.org/10.1016/j.metabol.2006.09.002

- Oxenkrug G. Insulin resistance and dysregulation of tryptophan–kynurenine and kynurenine–nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol. 2013; 48:294–301. DOI: https://doi.org/10.1007/s12035-013-8497-4

- Kotake Y, Ueda T, Mori T, Igaki S, Hattori M. Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA). Acta Vitaminol Enzymol. 1975;29(1–6):236–9.

- Moreno-Navarrete JM, Jove M, Ortega F, Xifra G, Ricart W, Obis È, et al. Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity. Diabetologia. 2016;59(4):822–32. DOI: https://doi.org/10.1007/s00125-016-3863-1

- Liu Z, Li P, Zhao ZH, Zhang Y, Ma ZM, Wang SX. Vitamin b6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in apoe−/− mice fed with high-fat diet. J Diabetes Res. 2016;2016. DOI: https://doi.org/10.1155/2016/1748065

- Nix WA, Zirwes R, Bangert V, Kaiser RP, Schilling M, Hostalek U, et al. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract. 2015;107(1):157–65. DOI: https://doi.org/10.1016/j.diabres.2014.09.058

- Horikawa C, Aida R, Kamada C, Fujihara K, Tanaka S, Tanaka S, et al. Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS). Eur J Nutr. 2020; 59:1585–94. DOI: https://doi.org/10.1007/s00394-019-02014-4

- Bennink HJ, Schreurs WH. Improvement of oral glucose tolerance in gestational diabetes by pyridoxine. Br Med J. 1975;3(5974):13–5. DOI: https://doi.org/10.1136/bmj.3.5974.13

- Leklem JE, Hollenbeck CB. Acute ingestion of glucose decreases plasma pyridoxal 5’-phosphate and total vitamin B-6 concentration. Am J Clin Nutr. 1990;51(5):832–6. DOI: https://doi.org/10.1093/ajcn/51.5.832

- Okada M, Shibuya M, Yamamoto E, Murakami Y. Effect of diabetes on vitamin B6 requirement in experimental animals. Diabetes Obes Metab. 1999;1(4):221–5. DOI: https://doi.org/10.1046/j.1463-1326.1999.00028.x

- Haidari F, Mohammadshahi M, Zarei M, Haghighizadeh MH, Mirzaee F. The Effect of Pyridoxine Hydrochloride Supplementation on Leptin, Adiponectin, Glycemic Indices, and Anthropometric Indices in Obese and Overweight Women. Clin Nutr Res. 2021;10(3):230. DOI: https://doi.org/10.7762/cnr.2021.10.3.230

- Khobrani M, Kandasamy G, Vasudevan R, Alhossan A, Puvvada RC, Devanandan P, et al. Impact of vitamin B6 deficiency on the severity of diabetic peripheral neuropathy–A cross sectional study. Saudi Pharmaceutical Journal. 2023;31(5):655–8.

- Haidari F, Mohammadshahi M, Zarei M, Haghighizadeh MH, Mirzaee F. Assessment of the Effect of Pyridoxine Hydrochloride Supplementation on Anthropometric Measurements, Body Composition, Visceral Adiposity Index and Metabolic Status in Obese and Overweight Women. 2020; DOI: https://doi.org/10.21203/rs.3.rs-39317/v1

- Jin G, Wang J, Jiang X. Association of folate, vitamin B-12 and vitamin B-6 intake with diabetes and prediabetes in adults aged 20 years and older. Asia Pac J Clin Nutr. 2021;30(1):75–86.

- Raghuvanshi DS, Chakole S, Kumar M. Relationship Between Vitamins and Diabetes. Cureus. 2023;15(3). DOI: https://doi.org/10.7759/cureus.36815

- Khobrani M, Kandasamy G, Vasudevan R, Alhossan A, Puvvada RC, Devanandan P, et al. Impact of vitamin B6 deficiency on the severity of diabetic peripheral neuropathy–A cross sectional study. Saudi Pharmaceutical Journal. 2023;31(5):655–8. DOI: https://doi.org/10.1016/j.jsps.2023.03.005

- Li J, Yin L, Wang L, Li J, Huang P, Yang H, et al. Effects of vitamin B6 on growth, diarrhea rate, intestinal morphology, function, and inflammatory factors expression in a high-protein diet fed to weaned piglets. J Anim Sci. 2019;97(12):4865–74. DOI: https://doi.org/10.1093/jas/skz338

- Hsu CC, Cheng CH, Hsu CL, Lee WJ, Huang SC, Huang YC. Role of vitamin B6 status on antioxidant defenses, glutathione, and related enzyme activities in mice with homocysteine-induced oxidative stress. Food Nutr Res. 2015;59(1):25702. DOI: https://doi.org/10.3402/fnr.v59.25702

- Abosamak NR, Gupta V. Vitamin B6 (pyridoxine). In: StatPearls [Internet]. StatPearls Publishing; 2023.

- Levin ER, Hanscom TA, Fisher M, Lauvstad WA, Lui A, Ryan A, et al. The influence of pyridoxine in diabetic peripheral neuropathy. Diabetes Care. 1981;4(6):606–9. DOI: https://doi.org/10.2337/diacare.4.6.606

- Jha SC, Dey S, Ranjan R. To determine the correlation between BMI and Glycated Hemoglobin (HbA1c) Level in Patients of Type 2 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine. 2022;9(3):3014–8.

- Lee EY, Lee Y ho, Yi SW, Shin SA, Yi JJ. BMI and all-cause mortality in normoglycemia, impaired fasting glucose, newly diagnosed diabetes, and prevalent diabetes: a cohort study. Diabetes Care. 2017;40(8):1026–33. DOI: https://doi.org/10.2337/dc16-1458

- Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi pharmaceutical journal. 2016;24(5):547–53. DOI: https://doi.org/10.1016/j.jsps.2015.03.013

- Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50(5):567–75. DOI: https://doi.org/10.1016/j.freeradbiomed.2010.12.006

- Aghamohammadi V, Gargari BP, Aliasgharzadeh A. Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J Am Coll Nutr. 2011;30(3):210–5. DOI: https://doi.org/10.1080/07315724.2011.10719962

- Bajaj S, Khan A. Antioxidants and diabetes. Indian J Endocrinol Metab. 2012;16(Suppl 2): S267. DOI: https://doi.org/10.4103/2230-8210.104057

- Bilski P, Li MY, Ehrenshaft M, Daub ME, Chignell CF. Vitamin B6 (pyridoxine) and its derivatives are efficient singlet oxygen quenchers and potential fungal antioxidants. Photochem Photobiol. 2000;71(2):129–34. DOI: https://doi.org/10.1562/0031-8655(2000)071<0129:SIPVBP>2.0.CO;2

Downloads

Published

2024-01-14

How to Cite

Moatamad Hanoon Dawood, Manal Khalid Abdulridha, & Hayder Saadoon Qasim. (2024). Impact of Pyridoxine Supplement on Oxidative Stress in Type 2 Diabetic Patients. Al Mustansiriyah Journal of Pharmaceutical Sciences, 24(1), 89–104. https://doi.org/10.32947/ajps.v24i1.1030